JPMorgan Chase & Co. Has Lowered Expectations for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its target price decreased by equities research analysts at JPMorgan Chase & Co. from $88.00 to $87.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 15.07% from the company’s current price.

A number of other equities analysts also recently issued reports on CL. Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a research report on Friday, October 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Raymond James Financial reduced their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Morgan Stanley set a $87.00 price objective on shares of Colgate-Palmolive and gave the company an “overweight” rating in a report on Monday. Finally, Citigroup restated a “buy” rating on shares of Colgate-Palmolive in a report on Monday. Nine research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $90.80.

Colgate-Palmolive Stock Down 1.9%

Shares of NYSE:CL traded down $1.45 during trading hours on Monday, hitting $75.60. The company’s stock had a trading volume of 3,648,797 shares, compared to its average volume of 5,410,491. Colgate-Palmolive has a 52 week low of $74.62 and a 52 week high of $100.18. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The company has a market capitalization of $61.10 billion, a price-to-earnings ratio of 21.21, a P/E/G ratio of 4.44 and a beta of 0.34. The firm’s fifty day moving average price is $80.45 and its 200 day moving average price is $86.28.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 EPS. As a group, research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Institutional Investors Weigh In On Colgate-Palmolive

Several institutional investors and hedge funds have recently added to or reduced their stakes in CL. Westside Investment Management Inc. boosted its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares during the last quarter. Cornerstone Planning Group LLC boosted its holdings in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares during the last quarter. Saudi Central Bank acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC boosted its holdings in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the last quarter. Finally, Ransom Advisory Ltd acquired a new position in Colgate-Palmolive during the first quarter worth $33,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.